Inyoung Kim, MD, PHD
NPI 1730567264 · Dermatology Physician · Chicago, IL
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1730567264
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD, PHD
- Sex
- Female
- Sole proprietor
- No
- License
- 036168465 (IL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
11 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
5 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
732 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 177 | $6 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 93 | $83 |
| Biopsy of Related Skin Growth, First Growth11102 | 72 | $85 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 72 | $119 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 58 | $48 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 102 | 45 |
| Triamcinolone Acetonide | 65 | 45 |
| Mupirocin | 63 | 45 |
| Doxycycline Hyclate | 61 | 45 |
| Betamethasone Dipropionate | 52 | 26 |
| Clobetasol Propionate | 34 | 20 |
| Cephalexin | 26 | 24 |
| Gentamicin Sulfate | 22 | 19 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$782 across 31 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (4)
- 1945 W Wilson Ave Ste 6119Chicago, IL 60640-5259Phone: (312) 319-1978Fax: (312) 262-7791
- 920 N York Rd Ste 100Hinsdale, IL 60521-3515Phone: (312) 319-1978Fax: (312) 262-7791
- 4905 Old Orchard Ctr Lowr LevelSkokie, IL 60077-1458Phone: (312) 319-1978Fax: (312) 262-7791
- 800 Macarthur Blvd Ste 6Munster, IN 46321-2917Phone: (219) 703-2417Fax: (219) 703-6947
Registry dates
- Enumerated
- 2015-05-17
- Last updated
- 2025-01-11
- Certified
- 2025-01-11
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.